Synthetic ion channels may have potential therapeutic applications, provided they possess appropriate biological activities. The present study was designed to examine the ability of small molecule-based synthetic Cl -channels to modulate airway smooth muscle responsiveness. Changes in isometric tension were measured in rat tracheal rings. Relaxations to the synthetic chloride channel SCC-1 were obtained during sustained contractions to KCl. The anion dependency of the effect of SCC-1 was evaluated by ion substitution experiments. The sensitivity to conventional Cl -transport inhibitors was also tested. SCC-1 caused concentration-dependent relaxations during sustained contractions to potassium chloride. This relaxing effect was dependent on the presence of extracellular Cl -and HCO 3 2 . It was insensitive to conventional Cl -channels/transport inhibitors that blocked the cystic fibrosis transmembrane conductance regulator and calcium-activated Cl -channels. SCC-1 did not inhibit contractions induced by carbachol, endothelin-1, 5-hydroxytryptamine or the calcium ionophore A23187. SCC-1 relaxes airway smooth muscle during contractions evoked by depolarizing solutions. The Cl -conductance conferred by this synthetic compound is distinct from the endogenous transport systems for chloride anions.
Introduction
Synthetic ion channels are of interest because of their potential therapeutic and research applications. Although several synthetic ion channels have been synthesized and characterized [1] [2] [3] [4] , little information is available concerning their biological effects. Indeed, most of the characterization were carried out on abiotic systems. Typically, ion transport activities were studied using liposomebased fluorescence assays and channel activities were documented in planar lipid bilayer experiments [2] . Whether ion transport activity observed in these systems can be extrapolated to biological systems is, however, uncertain. A few studies have demonstrated the abilities of synthetic ion channels to kill bacteria [5] [6] [7] [8] and to induce epithelial chloride (Cl -) secretion [9] [10] [11] [12] . The action of synthetic ion channels on other biological systems, however, remains elusive. Previous studies have demonstrated the abilities of a small molecule-based synthetic Cl -channel assemblage [13] to alter membrane potential, the intracellular calcium concentration ([Ca 2+ ] i ) and the contraction level in cultured vascular smooth muscle cells [14] .
Ligand-gated Cl -channels, c-aminobutyric acid type A (GABA A ) receptor, have been detected in both human and guinea pig airway smooth muscles [15] . In both guinea pig and human trachea, selective activation of these receptors in vitro reduces agonist-induced contractions [15, 16] and potentiates isoproterenol-mediated relaxation [16] . In vivo, selective GABA A agonists attenuate agonist-induced airway constriction when central parasympathetic, postganglionic sympathetic, and inhibitory nonadrenergic, noncholinergic (NANC) neural contributions to airway tone are eliminated, suggesting a direct effect on the airway smooth muscle GABA A receptor [17] . In addition, glycineactivated Cl -channel (GlyR) are expressed in guinea pig and human airway smooth muscle [18] . Like that of GABA A receptors, activation of GlyR relaxes agonist-contracted isolated airway smooth muscle and potentiates isoproterenol-mediated relaxation [18] . These observations prompted the investigation of biological activity of synthetic Cl -channels in airway smooth muscle. Thus, the present study was designed to examine the effect of SCC-1 [a synthetic molecule-derived ion channel, designed in the laboratory [13] , Fig. 1 ] on the responsiveness of the isolated trachea of the rat.
Results

SCC-1 Relaxed High-K
+ -induced Airway Smooth Muscles Contraction
Addition of SCC-1 relaxed tracheal rings contracted with 60 mM KCl ( Fig. 2A) . This relaxation was concentrationdependent and when the SCC-1 concentration in the bath reached 3610
25 M, the tension returned to the baseline level. Treating the tissues with muscarinic receptor antagonist atropine (10 26 M) did not affect the relaxing effects of SCC-1 ( Fig. 2A) . The KCl-induced contraction was attenuated significantly by atropine (see Fig. S1 ).
Since the addition of KCl raised the osmolarity of the bath solution, whether this hyperosmolarity influenced the activity of SCC-1 was in question. The problem was addressed by monitoring the effect of SCC-1 on preparations contracted with iso-osmotic high-K + solution and compared it to the hyperosmotic situation. The relaxing effects of SCC-1 were not significantly different in both cases (Fig. 2B) . To investigate the Cl -dependence of the action of SCC-1, high-K + -Cl --free solution was used to obtain the background contraction. In the absence of extracellular Cl -, the effect of SCC-1 was attenuated significantly (Fig. 2B ). In addition, the relaxing effect of SCC-1 on tracheae contracted by high-
HCO 3 2 -free solution was abolished (Fig. 2B) . However, without washing out SCC-1, the addition of 60 mM KCl to the organ chamber in the presence of high-K + -Cl 2/ HCO 3 2 -free solution caused relaxation (Fig. 2C) .
Alternatively, the effect of SCC-1 was assessed by treating the tissues prior to the cumulative addition of KCl. Fig. S2 ), preventing the use of that drug for further experiments. CFTR inh-172 at 10 25 M caused a modest but significant inhibition of the KCl-induced contraction, while DIDS at 10 24 M did not affect the response (see Fig. S2 ). At 10 25 M, CFTR inh-172 did not affect the relaxations to SCC-1, whereas Carbachol-, Endothelin-1-, 5-hydroxytryptamine-and A23187
Contractions to either carbachol (10 26 M) or endothelin-1 (10 27 M) were not significantly influenced by the cumulative addition of SCC-1 (10 26 23610 25 M) to the bath solution ( Fig. 5A and 5B). Treating the tracheal rings with SCC-1 at 10 25 M had no effect on subsequent contractions evoked by 5-hydroxytryptamine or A23187 (both at 10 26 M) ( Fig. 5C and 5D ). The preparations did not contract in response to bradykinin, tachykinins or histamine (see Fig. S3 ) and therefore the effect of SCC-1 on the response to these agonists could not be evaluated.
Discussion
The present study demonstrates that SCC-1 relaxes contractions of airway smooth muscle to high potassium in a Cl --dependent manner. By contrast, contractions elicited by carbachol, endothelin-1, 5-hydroxytryptamine and A23187 are not affected by the synthetic Cl -channel. The effects of SCC-1 on the contraction of the trachea to high potassium are reminiscent of the observations in vascular smooth muscle [14] . Presumably, the relaxant effects of SCC-1 are related to their ability to form artificial Cl -channels in cell membranes, which provide routes for transmembrane Cl -movement [13] . acetylcholine-induced contractions of airway smooth muscle are not blocked by L-type Ca 2+ channels blocker [23] , SCC-1 may affect the cholinergic component by inhibiting acetylcholine release from nerve terminals rather than by inhibiting the signaling pathway downstream of acetylcholine release. This interpretation was supported by the observation that SCC-1 did not affect carbachol-induced M 3 receptor-mediated contraction.
The present study demonstrated that the effects of SCC-1 were independent of hyperosmolarity and the ''high-Cl --'' condition caused by the addition of KCl to the bath. The presence of extracellular Cl -was important for the activities of SCC-1 as indicated by the findings that: 1) eliminating Cl -in the bath solution significantly attenuated the relaxing effects of SCC-1 and 2) while the latter failed to relax preparations contracted by high-K + -Cl 2/ HCO 3 2 -free solution, the relaxing effect was restored after addition of 60 mM KCl. Moreover, the residual relaxing effects of SCC-1 during contractions to high-K + -Cl --free solution were eliminated when HCO 3 2 was removed, suggesting that HCO 3 2 transport may also be involved in the actions of SCC-1. Likewise, CFTR, a natural Cl -channel, has been suggested to increase HCO 3 2 permeability at low extracellular Cl -levels [24] and to serve as HCO 3 2 channel [25] . The Cl -conductance conferred by SCC-1 may be novel as its effects were insensitive to both CFTR inh-172 and DIDS, the conventional inhibitors of CFTR [26] and most non-CFTR Cl -channels [27] , respectively. In an earlier study, CFTR inh-172 and another Cl -transport inhibitor DPC also did not affect the ability of SCC-1 to alter the membrane potential in Madin-Darby canine kidney (MDCK) cells [14] . Taken in conjunction, these findings suggest that SCC-1 forms synthetic Cl -channels in the cell membranes of airway smooth muscle.
SCC-1 also failed to inhibit contractions elicited by carbachol, endothelin-1 and 5-hydroxytryptamine. These contractile agonists activate G q -coupled receptors, leading to the generation of multiple secondary messengers, including IP 3 (which releases Ca 2+ from intracellular stores), diacylglycerol, and activation of multiple Ca 2+ channel types [28] . Bronchoconstrictors depolarize airway smooth muscle membrane [29] [30] [31] , primarily by activation of Cl -and non-selective cation currents as well as suppression of K + currents [30, 31] . However, whether or not agonist-evoked contraction depends on Ca 2+ influx via L-type Ca 2+ channels remains controversial [32] . Indeed, some studies show that agonist-induced contraction of airway smooth muscles are not affected by L-type Ca 2+ channels blockers [29, 33] . When the membrane potential was clamped at negative values below the activation threshold (-40 to -30 mV) for L-type Ca 2+ channels, agonist-induced contractions are still observed [34] . Moreover, the normal range of membrane potentials (-70 to -30 mV) observed in airway smooth muscles [32, [35] [36] [37] [38] [39] [40] is presumably too negative to activate L-type Ca 2+ channels (220 to +30 mV) [32, [41] [42] [43] [44] and even at agonist concentrations reaching maximal contractile effects, the membrane potential is at a level that can only marginally activate L-type Ca 2+ channels [32] . These studies prompt the suggestion that agonist stimulation is incapable of depolarizing the membrane to an extent that is sufficient to trigger significant voltage-dependent Ca 2+ influx in airway smooth muscles. This conclusion is supported by the clinical findings that L-type Ca 2+ channel blockers are relatively ineffective against asthma [45, 46] . If agonist-induced contractions of airway smooth muscle do not rely on voltage-dependent Ca 2+ influx, modulation of voltage-dependent Ca 2+ influx by synthetic Cl -channels should not inhibit them.
In conclusion, the present study demonstrates the ability of SCC-1 to relax contracted airway smooth muscle. This relaxing effect partially depends on extracellular Cl -, consistent with the postulated Cl -channel function conferred by SCC-1. The synthetic molecule-derived Cl -conductance is novel because it is not inhibited by conventional Cl -transport inhibitors. On the other hand, SCC-1 does not prevent agonist-induced contractions, which is explained by the voltage-independent nature of these responses.
Materials and Methods
Ethics Statement, Tissue Preparation and Isometric Tension Measurement
This investigation was approved by the Committee on the Use of Laboratory Animals for Teaching and Research of the University of Hong Kong. Adult male 12-weeks-old SpragueDawley rats (300-400 g) were maintained under a 12-h light/dark cycle at 2161uC and were fed with standard laboratory chow (LabDiet 5053, USA) and tap water ad libitum. After being euthanized with pentobarbital sodium (70 mg/ml/kg, i.p.), their chest cavity was opened, and the lungs were removed en bloc and placed immediately into cold oxygenated Krebs-Henseleit solution of the following composition: 120 mM NaCl, 25 mM NaHCO 3 , 5.5 mM glucose, 4.76 mM KCl, 1.18 mM MgSO 4 ?7H 2 O, 1.18 mM NaH 2 PO 4 ?2H 2 O and 1.25 mM CaCl 2 ?2H 2 O (control solution). The trachea was dissected free of connective tissues and fat and cut into rings (2-3 mm width). The rings were suspended between two stainless steel hooks in organ chambers filled with 5 mL of control solution. One of the hooks was attached to the organ chamber and the other was connected to a force transducer (AD Instruments, model MLT0201/D, Bella Vista, Australia) for isometric force recording. The bathing solution was maintained at 37uC and continuously aerated with a mixture of 95% O 2 and 5% CO 2 . The rings were allowed to equilibrate under 1 g of tension for 60 min with bathing solution changes every 15 min. During the equilibration, the tension was adjusted to 1 g, except for the last 30 min.
High 
Effect of SCC-1 on Contractions
Each tracheal ring was contracted with the agonist at the indicated concentration and was allowed to achieve a steady-state plateau. SCC-1 was then added to the bath in a cumulative fashion (10 Alternatively, the effect of the synthetic ion channels was determined by adding a single concentration of the compound to the organ chamber 30 min before the addition of contractile agonists and observing how the airway smooth muscle contractility was altered. In this case, the concentration of the tested compound was maintained throughout the experiment. This protocol was primarily used for agonists that induced transient contraction, namely 5-hydroxytryptamine and A23187.
Cl
-Transport Inhibitors 
Chemicals and Drugs
4,49-Diisothiocyanato-stilbene-2,29-disulphonic acid (DIDS), 5-hydroxytryptamine (5-HT), the calcium ionophore A23187, carbachol and endothelin-1 were purchased from Sigma Chemicals Co. (St. Louis, MO, USA); CFTR inh-172 from Calbiochem (San Diego, CA, USA) and atropine sulfate from Merck (Darmstadt, Germany). Stock solutions of N1,N3-bis((R)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yloxy)isophthalamide, or SSC-1 (synthesized in the laboratory, Fig. 1 ), A23187, CFTR inh-172 and DIDS stock were prepared in dimethylsulfoxide (DMSO) while all stock solutions of the remaining drugs were dissolved in de-ionized water.
Data and Statistical Analysis
Data are presented as means 6 standard error of the means (SEM), and n indicates the number of rats used in the experiments. Changes in tension were expressed as a percentage of the reference contraction in response to the addition of KCl (60 mM). Relaxation to SCC-1 was expressed as percent reduction of active force (the difference between baseline tension and peak tension generated by contractile agonists). For concentration-response studies, the data were fit by non-linear regression analysis where appropriate. Maximal contractions and EC 50 (the concentration of agonist required to produce 50% of the maximal response) were determined. Statistical analysis was performed using two-tailed unpaired Student's t-tests or ANOVA followed by Bonferroni's or Dunnett's post hoc comparison as appropriate. All statistical procedures were computed using Prism version 5.01 (GraphPad Software, San Diego, CA, USA). P-values less than 0.05 were considered to indicate statistically significant differences. 
Supporting Information
